142 related articles for article (PubMed ID: 25603273)
1. Response criteria for malignant lymphoma.
Maffione AM; Paolini R; Rodella E; Ambrosio C; Rampin L; Lisato LC; Ballotta M; Pavanato G; Rubello D
Nucl Med Commun; 2015 Apr; 36(4):398-405. PubMed ID: 25603273
[TBL] [Abstract][Full Text] [Related]
2. Staging and response assessment in lymphomas: the new Lugano classification.
Cheson BD
Chin Clin Oncol; 2015 Mar; 4(1):5. PubMed ID: 25841712
[TBL] [Abstract][Full Text] [Related]
3. Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma.
Juweid ME; Stroobants S; Hoekstra OS; Mottaghy FM; Dietlein M; Guermazi A; Wiseman GA; Kostakoglu L; Scheidhauer K; Buck A; Naumann R; Spaepen K; Hicks RJ; Weber WA; Reske SN; Schwaiger M; Schwartz LH; Zijlstra JM; Siegel BA; Cheson BD;
J Clin Oncol; 2007 Feb; 25(5):571-8. PubMed ID: 17242397
[TBL] [Abstract][Full Text] [Related]
4. [Response criteria for malignant lymphoma].
Ganten MK
Radiologe; 2012 Apr; 52(4):330-7. PubMed ID: 22418972
[TBL] [Abstract][Full Text] [Related]
5. Is contrast material needed after treatment of malignant lymphoma in positron emission tomography/computed tomography?
Nakamoto Y; Nogami M; Sugihara R; Sugimura K; Senda M; Togashi K
Ann Nucl Med; 2011 Feb; 25(2):93-9. PubMed ID: 20957527
[TBL] [Abstract][Full Text] [Related]
6. Impact of FDG-PET/CT in the management of lymphoma.
Baba S; Abe K; Isoda T; Maruoka Y; Sasaki M; Honda H
Ann Nucl Med; 2011 Dec; 25(10):701-16. PubMed ID: 22037934
[TBL] [Abstract][Full Text] [Related]
7. Criteria-Based Imaging and Response Evaluation of Lymphoma 20 Years After Cheson: What is New?
Skusa C; Weber MA; Böttcher S; Thierfelder KM
Rofo; 2020 Jul; 192(7):657-668. PubMed ID: 32215902
[TBL] [Abstract][Full Text] [Related]
8. Use of PET/CT to evaluate response to therapy in lymphoma.
Zanoni L; Cerci JJ; Fanti S
Q J Nucl Med Mol Imaging; 2011 Dec; 55(6):633-47. PubMed ID: 22231583
[TBL] [Abstract][Full Text] [Related]
9. PET/CT: appropriate application in lymphoma.
Wang X
Chin Clin Oncol; 2015 Mar; 4(1):4. PubMed ID: 25841711
[TBL] [Abstract][Full Text] [Related]
10. [Malignant lymphoma: therapy and assessment of the course].
Delorme S
Radiologe; 2012 Apr; 52(4):320. PubMed ID: 22454099
[No Abstract] [Full Text] [Related]
11. [The role of positron emission tomography in in lymphoma diagnosis and treatment].
Papamichael DC; Pianou NK; Chatzipavlidou V
Hell J Nucl Med; 2015; 18(2):173-9. PubMed ID: 26187221
[TBL] [Abstract][Full Text] [Related]
12. Radiological evaluation of the therapeutic response of malignant diseases: status quo, innovative developments and requirements for radiology.
Höink AJ; Heindel W; Buerke B
Rofo; 2014 Oct; 186(10):927-36. PubMed ID: 25122173
[TBL] [Abstract][Full Text] [Related]
13. Leukemia and lymphoma.
Guillerman RP; Voss SD; Parker BR
Radiol Clin North Am; 2011 Jul; 49(4):767-97, vii. PubMed ID: 21807173
[TBL] [Abstract][Full Text] [Related]
14. FDG PET/CT versus CT, MR imaging, and 67Ga scintigraphy in the posttherapy evaluation of malignant lymphoma.
Okada M; Sato N; Ishii K; Matsumura K; Hosono M; Murakami T
Radiographics; 2010; 30(4):939-57. PubMed ID: 20631361
[TBL] [Abstract][Full Text] [Related]
15. The place of positron emission tomography imaging in the management of patients with malignant lymphoma.
Jerusalem G; Beguin Y
Haematologica; 2006 Apr; 91(4):442-4. PubMed ID: 16585010
[No Abstract] [Full Text] [Related]
16. [Imaging examinations in lymphoma].
Terauchi T
Nihon Rinsho; 2014 Mar; 72(3):430-5. PubMed ID: 24724398
[TBL] [Abstract][Full Text] [Related]
17. [Diagnostic imaging of lymphomas].
Casasnovas O
Rev Prat; 2010 Jan; 60(1):53-8. PubMed ID: 20222312
[TBL] [Abstract][Full Text] [Related]
18. PET imaging for response assessment in lymphoma: potential and limitations.
Schöder H; Moskowitz C
Radiol Clin North Am; 2008 Mar; 46(2):225-41, viii. PubMed ID: 18619378
[TBL] [Abstract][Full Text] [Related]
19. Primary central nervous system lymphoma: an update.
Soussain C; Hoang-Xuan K
Curr Opin Oncol; 2009 Nov; 21(6):550-8. PubMed ID: 19684518
[TBL] [Abstract][Full Text] [Related]
20. PET/CT for therapy response assessment in lymphoma.
Hutchings M; Barrington SF
J Nucl Med; 2009 May; 50 Suppl 1():21S-30S. PubMed ID: 19380407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
